COVID-19: closing in on matching therapeutic mechanism to disease stage
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
In the history of infectious diseases, no single disease has had even remotely as many mechanisms or products tested at the same time as COVID-19.
With nearly 50 therapies in clinical trials due to yield data by the end of June, the needle should start to move on what works and doesn’t. The agents, all repurposed, map to a dozen different mechanisms, and the trials could help determine the disease stages at which they are most useful...